WAM
Werlinich Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Sell |
94,300
-4,135
| -4% | -$100K | 1.25% | 22 |
|
|
2025
Q1 | $2.49M | Buy |
98,435
+5,700
| +6% | +$144K | 1.58% | 21 |
|
|
2024
Q4 | $2.45M | Buy |
92,735
+2,350
| +3% | +$62.1K | 1.43% | 23 |
|
|
2024
Q3 | $2.62M | Buy |
90,385
+225
| +0.2% | +$6.51K | 1.52% | 20 |
|
|
2024
Q2 | $2.51M | Buy |
90,160
+1,350
| +2% | +$37.5K | 1.56% | 21 |
|
|
2024
Q1 | $2.47M | Buy |
88,810
+9,063
| +11% | +$252K | 1.61% | 20 |
|
|
2023
Q4 | $2.28M | Buy |
79,747
+2,197
| +3% | +$62.9K | 1.73% | 18 |
|
|
2023
Q3 | $2.57M | Sell |
77,550
-1,150
| -1% | -$38.1K | 2.12% | 16 |
|
|
2023
Q2 | $2.89M | Buy |
78,700
+1,900
| +2% | +$69.7K | 2.32% | 14 |
|
|
2023
Q1 | $3.13M | Buy |
76,800
+290
| +0.4% | +$11.8K | 2.75% | 11 |
|
|
2022
Q4 | $3.92M | Buy |
76,510
+365
| +0.5% | +$18.7K | 3.63% | 8 |
|
|
2022
Q3 | $3.33M | Sell |
76,145
-300
| -0.4% | -$13.1K | 3.41% | 10 |
|
|
2022
Q2 | $4.01M | Sell |
76,445
-1,000
| -1% | -$52.4K | 3.75% | 7 |
|
|
2022
Q1 | $4.01M | Buy |
77,445
+110
| +0.1% | +$5.7K | 3.05% | 10 |
|
|
2021
Q4 | $4.57M | Hold |
77,335
| – | – | 3.33% | 9 |
|
|
2021
Q3 | $3.33M | Sell |
77,335
-10,240
| -12% | -$440K | 2.69% | 10 |
|
|
2021
Q2 | $3.43M | Hold |
87,575
| – | – | 2.77% | 11 |
|
|
2021
Q1 | $3.17M | Buy |
+87,575
| New | +$3.17M | 2.79% | 9 |
|